The proinflammatory peptide substance P promotes blood-brain barrier breaching by breast cancer cells through changes in microvascular endothelial cell tight junctions.
Neuropeptide substance P (SP) has been implicated in inflammation, pain, depression and breast cancer cell (BCC) growth. Here, we examined the role of SP in trafficking of BCCs (human MDA-MB-231 and MDA-MB-231BrM2 cells) across the blood-brain barrier (BBB) and brain microvascular endothelial cells (BMECs) using in vitro and in vivo models. SP was secreted from BCCs and mediated adhesion and transmigration of BCCs across human BMECs (HBMECs) in vitro. SP induced activation of HBMECs, leading to secretion of Tumor Necrosis Factor alpha (TNF-α) and angiopoietin-2 (Ang-2) from HBMECs, resulting in changes in localization and distribution of tight junction (TJ) ZO-1 (tight junction protein zonula occludins-1) and claudin-5 structures as well as increased permeability of HBMECs. Using spontaneous breast cancer metastasis mouse model (syngeneic) of GFP-4T1-BrM5 mammary tumor cells administered into mammary fat pads of Balb/c mice, SP inhibitor spantide III inhibited in vivo changes in permeability of the BBB and BMEC-TJs ZO-1 and claudin-5 structures as well as decreased tumor cell colonization in brain. Thus, SP secreted from BCCs induces transmigration of BCCs across the BBB, leading to activation of BMECs and secretion of TNF-α and Ang-2, resulting in BBB impairment and colonization of tumor cells in brain. Therefore, therapies based on SP inhibition in combination with other therapies may prevent breaching of the BBB by BCCs and their colonization in brain.
The Division of Experimental Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA.
Pedro L
PL
Rodriguez
Shuxian
S
Jiang
Yigong
Y
Fu
Shalom
S
Avraham
Hava Karsenty
HK
Avraham
D000818:Animals; D001812:Blood-Brain Barrier; D001943:Breast Neoplasms / Q000473:pathology*; D002448:Cell Adhesion; D002465:Cell Movement; D003599:Cytoskeleton / Q000737:chemistry; D042783:Endothelial Cells / Q000502:physiology*; D005260:Female; D006801:Humans; D051379:Mice; D055806:Microvessels / Q000166:cytology; D010539:Permeability; D013373:Substance P / Q000031:analogs & derivatives / Q000037:antagonists & inhibitors / Q000494:pharmacology / Q000502:physiology*; D019108:Tight Junctions / Q000502:physiology*; D014409:Tumor Necrosis Factor-alpha / Q000378:metabolism
D014409:Tumor Necrosis Factor-alpha; C408989:spantide III; D013373:Substance P
BBB; BMECs; SP; TJ ZO-1; breast tumor metastasis; claudin-5